IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Royalty Pharma Sub-Manager, LLC

Q2 2026 Holdings

Filed 2026-08-14 | 4 holdings | $241.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2026-08-21) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics, Inc(CYTK)COM23282W605$83.5M980,39234.5%
Zenas Biopharma, Inc.(ZBIO)ACOM98937L105$60.6M2,388,15025.1%
Zenas Biopharma, Inc.(BCAX)COM055477103$60.6M2,388,15025.1%
Kailera Therapeutics(KLRA)COM482931102$54.1M2,455,35722.4%
Biohaven LTD(BHVN)COMG1110E107$43.7M2,936,50718.1%